Hangzhou Tian-Mu-Shan Pharmaceutical Enterprise Co.,Ltd. Posted 27.5 Million Yuan Net Loss in First Three Quarters of 2023

Hangzhou Tian-Mu-Shan Pharmaceutical Enterprise Co.,Ltd. (杭州天目山药业股份有限公司) (600671.SH) reported a net loss of 27.5 million yuan in the first three quarters of 2023, narrowing 20.1% year-on-year.

Meanwhile, the company posted 86.1 million yuan in revenue, up 10% year-on-year.

At the end of the reporting period, it had 340.4 million yuan in total assets and 362.8 million yuan in total liabilities, with a liability-to-asset ratio of 106.6%.